Literature DB >> 12653545

Activation of phenylalanine hydroxylase: effect of substitutions at Arg68 and Cys237.

Matthías Thórólfsson1, Knut Teigen, Aurora Martínez.   

Abstract

Phenylalanine hydroxylase (PAH) is a multidomain tetrameric enzyme that displays positive cooperative substrate binding. This cooperative response is believed to be of physiological significance as a mechanism that controls L-Phe homeostasis in blood. The substrate induces an activating conformational change in the enzyme affecting the secondary, tertiary, and quaternary structures. Chemical modification and substitution with a negatively charged residue of Cys237 in human PAH (hPAH) also result in activation of the enzyme. As seen in the modeled structure of full-length hPAH, Cys237 is located in the catalytic domain close to residues in the oligomerization and regulatory domains of an adjacent subunit in the dimer, notably to Arg68. This residue is located in a prominent loop (68-75), which also has contacts with the dimerization motif from the same subunit. To investigate further the involvement of Cys237 and Arg68 in the activation of the enzyme, we have prepared mutants of hPAH at these positions, with substitutions of different charge and size. The mutations C237D, R68A, and C237A cause an increase of the basal activity and affinity for L-Phe, while the mutation C237R results in reduced affinity for the substrate and elimination of the positive cooperativity. The conformational changes induced by the mutations were studied by far-UV circular dichroism, fluorescence spectroscopy, and molecular dynamics simulations. All together, our results indicate that the activating mutations induce a series of conformational changes including both the displacement of the inhibitory N-terminal sequence (residues 19-33) that covers the active site and the domain movements around the hinge region Arg111-Thr117, in addition to the rearrangement of the loop 68-75. The same conformational changes appear to be involved in the activation of PAH induced by L-Phe.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653545     DOI: 10.1021/bi034021s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

Review 1.  Allosteric regulation of phenylalanine hydroxylase.

Authors:  Paul F Fitzpatrick
Journal:  Arch Biochem Biophys       Date:  2011-10-07       Impact factor: 4.013

2.  The phenylketonuria-associated substitution R68S converts phenylalanine hydroxylase to a constitutively active enzyme but reduces its stability.

Authors:  Crystal A Khan; Steve P Meisburger; Nozomi Ando; Paul F Fitzpatrick
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

3.  A new model for allosteric regulation of phenylalanine hydroxylase: implications for disease and therapeutics.

Authors:  Eileen K Jaffe; Linda Stith; Sarah H Lawrence; Mark Andrake; Roland L Dunbrack
Journal:  Arch Biochem Biophys       Date:  2013-01-11       Impact factor: 4.013

Review 4.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

5.  Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations.

Authors:  Heidi Erlandsen; Angel L Pey; Alejandra Gámez; Belén Pérez; Lourdes R Desviat; Cristina Aguado; Richard Koch; Sankar Surendran; Stephen Tyring; Reuben Matalon; Charles R Scriver; Magdalena Ugarte; Aurora Martínez; Raymond C Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-19       Impact factor: 11.205

6.  Activation of phenylalanine hydroxylase induces positive cooperativity toward the natural cofactor.

Authors:  Søren W Gersting; Michael Staudigl; Marietta S Truger; Dunja D Messing; Marta K Danecka; Christian P Sommerhoff; Kristina F Kemter; Ania C Muntau
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

7.  Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases.

Authors:  Angel L Pey; Francois Stricher; Luis Serrano; Aurora Martinez
Journal:  Am J Hum Genet       Date:  2007-10-02       Impact factor: 11.025

8.  Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability.

Authors:  Søren W Gersting; Kristina F Kemter; Michael Staudigl; Dunja D Messing; Marta K Danecka; Florian B Lagler; Christian P Sommerhoff; Adelbert A Roscher; Ania C Muntau
Journal:  Am J Hum Genet       Date:  2008-06-05       Impact factor: 11.025

9.  Structural and stability effects of phosphorylation: Localized structural changes in phenylalanine hydroxylase.

Authors:  Frederico Faria Miranda; Matthías Thórólfsson; Knut Teigen; Jose M Sanchez-Ruiz; Aurora Martínez
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

10.  Phenylalanine hydroxylase from Legionella pneumophila is a thermostable enzyme with a major functional role in pyomelanin synthesis.

Authors:  Marte I Flydal; Christa H Chatfield; Huaixin Zheng; Felizza F Gunderson; Oscar Aubi; Nicholas P Cianciotto; Aurora Martinez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.